GLP-1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation.

Hurtado RL, Amato AA, de Luca Corrêa H, Silveira D

DOI: 10.1111/dom.70609
Published: 2026 May
Container: Diabetes, obesity & metabolism
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dom.70609,
  title = {GLP-1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation.},
  author = {Hurtado RL and Amato AA and de Luca Corrêa H and Silveira D},
  year = {2026},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.70609},
  url = {https://doi.org/10.1111/dom.70609}
}

RIS

TY  - JOUR
TI  - GLP-1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation.
AU  - Hurtado RL
AU  - Amato AA
AU  - de Luca Corrêa H
AU  - Silveira D
PY  - 2026
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.70609
UR  - https://doi.org/10.1111/dom.70609
ER  -

APA

RL, H., AA, A., H, D. L. C., & D, S. (2026). GLP-1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70609

Source records

pubmed · retrieved 2026-11-10T20:12:06.419Z